- Home
- BNR vs WIMI Comparison
BNR vs WIMI Comparison
Compare BNR & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- WIMI
- Stock Information
- Founded
- BNR 2014
- WIMI 2015
- Country
- BNR China
- WIMI China
- Employees
- BNR N/A
- WIMI 107
- Industry
- BNR Medical Specialities
- WIMI Computer Software: Prepackaged Software
- Sector
- BNR Health Care
- WIMI Technology
- Exchange
- BNR Nasdaq
- WIMI Nasdaq
- Market Cap
- BNR 38.3M
- WIMI 32.4M
- IPO Year
- BNR 2020
- WIMI 2020
- Fundamental
- Price
- BNR $6.79
- WIMI $3.57
- Analyst Decision
- BNR
- WIMI
- Analyst Count
- BNR 0
- WIMI 0
- Target Price
- BNR N/A
- WIMI N/A
- AVG Volume (30 Days)
- BNR 58.0K
- WIMI 7.6M
- Earning Date
- BNR 08-21-2025
- WIMI 01-01-0001
- Dividend Yield
- BNR N/A
- WIMI N/A
- EPS Growth
- BNR N/A
- WIMI N/A
- EPS
- BNR N/A
- WIMI N/A
- Revenue
- BNR $72,112,038.00
- WIMI $84,137,968.00
- Revenue This Year
- BNR $136.32
- WIMI N/A
- Revenue Next Year
- BNR N/A
- WIMI N/A
- P/E Ratio
- BNR N/A
- WIMI N/A
- Revenue Growth
- BNR 0.53
- WIMI 19.25
- 52 Week Low
- BNR $2.18
- WIMI $0.27
- 52 Week High
- BNR $9.48
- WIMI $2.92
- Technical
- Relative Strength Index (RSI)
- BNR 58.58
- WIMI 59.29
- Support Level
- BNR $6.03
- WIMI $3.43
- Resistance Level
- BNR $7.80
- WIMI $3.70
- Average True Range (ATR)
- BNR 1.00
- WIMI 0.32
- MACD
- BNR -0.08
- WIMI -0.01
- Stochastic Oscillator
- BNR 32.51
- WIMI 56.95
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.